AI platform for medicinal chemistry used to discover and develop small-molecule medicines for biopharma partners.
Proton is PostEra's proprietary AI platform for medicinal chemistry applied to small-molecule drug discovery. PostEra uses Proton to advance drug programs through partnerships with biopharma companies including Pfizer (expanded to $610M collaboration) and Amgen, together exceeding $1B in AI drug discovery deals. PostEra also led the COVID Moonshot, the world's largest open-science drug discovery effort, using the platform. Proton is a product of PostEra.